ALRAZI

Al Razi Medical Company

9572StocksTadawulConsumer Discretionary

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Annual (SAR)

	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	4.96M	5.78M	2.05M	-1.71M
Free Cash Flow	1.10M	1.00M	-0.64M	-2.82M
Capital Expenditures	-3.86M	-4.78M	-2.69M	-1.11M
Investing & Financing
Investing Cash Flow	-3.87M	-5.04M	-2.92M	-1.15M
Financing Cash Flow	-1.02M	-1.29M	-5.45M	10.33M
Dividends Paid	—	-2.41M	-1.89M	—
Operating Activities
Operating Cash Flow	4.96M	5.78M	2.05M	-1.71M
Net Income	0.18M	0.69M	2.01M	2.16M
Change in Accounts Payable	-2.71M	0.59M	1.81M	-1.08M
Change in Accounts Receivable	-1.31M	-0.03M	-0.57M	-0.14M
Change in Inventory	3.24M	0.43M	-5.31M	-1.61M
Change in Other Net Operating Assets	1.16M	-0.32M	0.90M	-3.64M
Change in Working Capital	0.37M	0.67M	-3.17M	-6.47M
Other Operating Activities	582.66K	725.65K	524.97K	601.93K
Provision & Write-off of Bad Debts	—	9.68K	7.61K	—
Depreciation & Amortization	3.83M	3.69M	2.68M	2.00M
Investing Activities
Investing Cash Flow	-3.87M	-5.04M	-2.92M	-1.15M
Capital Expenditures	-3.86M	-4.78M	-2.69M	-1.11M
Sale (Purchase) of Intangibles	-9.78K	-287.04K	-229.38K	-41.50K
Sale of Property, Plant & Equipment	—	25.00K	—	—
Loss (Gain) From Sale of Assets	—	-6.22K	—	—
Financing Activities
Financing Cash Flow	-1.02M	-1.29M	-5.45M	10.33M
Common Dividends Paid	—	-2.41M	-1.89M	—
Issuance of Common Stock	—	—	—	12.40M
Long-Term Debt Issued	3.00M	3.00M	—	—
Long-Term Debt Repaid	-3.76M	-2.28M	-2.87M	-2.02M
Net Debt Issued (Repaid)	-0.76M	0.72M	-2.87M	-2.02M
Other Financing Activities	-265.16K	402.26K	-692.06K	-50.00K
Free Cash Flow & Returns
Free Cash Flow	1.10M	1.00M	-0.64M	-2.82M
Free Cash Flow Growth	+10.3%	—	—	—
Free Cash Flow Margin	+1.8%	+1.6%	-1.2%	-6.3%
Free Cash Flow Per Share	0.72	0.66	-0.42	-1.86
Levered Free Cash Flow	1.05M	-0.16M	-1.88M	—
Unlevered Free Cash Flow	1.37M	0.14M	-1.70M	—
Operating Cash Flow Growth	-14.2%	+181.3%	—	—
Net Cash Flow	0.07M	-0.55M	-6.32M	7.47M

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Annual (SAR)

	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	4.96M	5.78M	2.05M	-1.71M
Free Cash Flow	1.10M	1.00M	-0.64M	-2.82M
Capital Expenditures	-3.86M	-4.78M	-2.69M	-1.11M
Investing & Financing
Investing Cash Flow	-3.87M	-5.04M	-2.92M	-1.15M
Financing Cash Flow	-1.02M	-1.29M	-5.45M	10.33M
Dividends Paid	—	-2.41M	-1.89M	—
Operating Activities
Operating Cash Flow	4.96M	5.78M	2.05M	-1.71M
Net Income	0.18M	0.69M	2.01M	2.16M
Change in Accounts Payable	-2.71M	0.59M	1.81M	-1.08M
Change in Accounts Receivable	-1.31M	-0.03M	-0.57M	-0.14M
Change in Inventory	3.24M	0.43M	-5.31M	-1.61M
Change in Other Net Operating Assets	1.16M	-0.32M	0.90M	-3.64M
Change in Working Capital	0.37M	0.67M	-3.17M	-6.47M
Other Operating Activities	582.66K	725.65K	524.97K	601.93K
Provision & Write-off of Bad Debts	—	9.68K	7.61K	—
Depreciation & Amortization	3.83M	3.69M	2.68M	2.00M
Investing Activities
Investing Cash Flow	-3.87M	-5.04M	-2.92M	-1.15M
Capital Expenditures	-3.86M	-4.78M	-2.69M	-1.11M
Sale (Purchase) of Intangibles	-9.78K	-287.04K	-229.38K	-41.50K
Sale of Property, Plant & Equipment	—	25.00K	—	—
Loss (Gain) From Sale of Assets	—	-6.22K	—	—
Financing Activities
Financing Cash Flow	-1.02M	-1.29M	-5.45M	10.33M
Common Dividends Paid	—	-2.41M	-1.89M	—
Issuance of Common Stock	—	—	—	12.40M
Long-Term Debt Issued	3.00M	3.00M	—	—
Long-Term Debt Repaid	-3.76M	-2.28M	-2.87M	-2.02M
Net Debt Issued (Repaid)	-0.76M	0.72M	-2.87M	-2.02M
Other Financing Activities	-265.16K	402.26K	-692.06K	-50.00K
Free Cash Flow & Returns
Free Cash Flow	1.10M	1.00M	-0.64M	-2.82M
Free Cash Flow Growth	+10.3%	—	—	—
Free Cash Flow Margin	+1.8%	+1.6%	-1.2%	-6.3%
Free Cash Flow Per Share	0.72	0.66	-0.42	-1.86
Levered Free Cash Flow	1.05M	-0.16M	-1.88M	—
Unlevered Free Cash Flow	1.37M	0.14M	-1.70M	—
Operating Cash Flow Growth	-14.2%	+181.3%	—	—
Net Cash Flow	0.07M	-0.55M	-6.32M	7.47M